GILDER GAGNON HOWE & CO LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 120 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.5%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$388,000
-12.8%
7,028
-0.3%
0.00%
-33.3%
Q2 2020$445,000
+44400.0%
7,050
+54130.8%
0.00%
Q1 2020$1,000
-100.0%
13
-100.0%
0.00%
-100.0%
Q4 2019$4,114,000
+1082.2%
51,755
+484.5%
0.04%
+760.0%
Q4 2017$348,000
+22.5%
8,854
-3.1%
0.01%
+25.0%
Q3 2017$284,000
+13.1%
9,133
-0.4%
0.00%0.0%
Q2 2017$251,000
-27.2%
9,170
-1.9%
0.00%
-33.3%
Q1 2017$345,000
-96.4%
9,350
-96.9%
0.01%
-96.1%
Q4 2015$9,604,000297,0530.15%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders